54 86

Cited 8 times in

Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma

Authors
 Bu-Yeo Kim  ;  Dong Wook Choi  ;  Seon Rang Woo  ;  Eun-Ran Park  ;  Je-Geun Lee  ;  Su-Hyeon Kim  ;  Imhoi Koo  ;  Sun-Hoo Park  ;  Chul Ju Han  ;  Sang Bum Kim  ;  Young Il Yeom  ;  Suk-Jin Yang  ;  Ami Yu  ;  Jae Won Lee  ;  Ja June Jang  ;  Myung-Haing Cho  ;  Won Kyung Jeon  ;  Young Nyun Park  ;  Kyung-Suk Suh  ;  Kee-Ho Lee 
Citation
 BMC Genomics, Vol.16 : 279, 2015 
Journal Title
 BMC Genomics 
ISSN
 1471-2164 
Issue Date
2015
Abstract
BACKGROUND: Despite the recent identification of several prognostic gene signatures, the lack of common genes among experimental cohorts has posed a considerable challenge in uncovering the molecular basis underlying hepatocellular carcinoma (HCC) recurrence for application in clinical purposes. To overcome the limitations of individual gene-based analysis, we applied a pathway-based approach for analysis of HCC recurrence. RESULTS: By implementing a permutation-based semi-supervised principal component analysis algorithm using the optimal principal component, we selected sixty-four pathways associated with hepatitis B virus (HBV)-positive HCC recurrence (p < 0.01), from our microarray dataset composed of 142 HBV-positive HCCs. In relation to the public HBV- and public hepatitis C virus (HCV)-positive HCC datasets, we detected 46 (71.9%) and 18 (28.1%) common recurrence-associated pathways, respectively. However, overlap of recurrence-associated genes between datasets was rare, further supporting the utility of the pathway-based approach for recurrence analysis between different HCC datasets. Non-supervised clustering of the 64 recurrence-associated pathways facilitated the classification of HCC patients into high- and low-risk subgroups, based on risk of recurrence (p < 0.0001). The pathways identified were additionally successfully applied to discriminate subgroups depending on recurrence risk within the public HCC datasets. Through multivariate analysis, these recurrence-associated pathways were identified as an independent prognostic factor (p < 0.0001) along with tumor number, tumor size and Edmondson's grade. Moreover, the pathway-based approach had a clinical advantage in terms of discriminating the high-risk subgroup (N = 12) among patients (N = 26) with small HCC (<3 cm). CONCLUSIONS: Using pathway-based analysis, we successfully identified the pathways involved in recurrence of HBV-positive HCC that may be effectively used as prognostic markers.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141038
DOI
10.1186/s12864-015-1472-x
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실)
Yonsei Authors
박영년(Park, Young Nyun)
사서에게 알리기
  feedback
Files in This Item:
T201503330.pdf Download
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse